Analyst firms · Morgan Stanley · LFST
Morgan Stanley LFST price target and rating history
LifeStance Health Group Inc. (LFST) · Health Care
Morgan Stanley rates LifeStance Health Group Inc. (LFST) Overweight with a $8 price target, as of its latest action on Jan 6, 2023. It has published 3 rating actions on LFST since August 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a LFST price target in the last 12 months, the median target is $8.
- Current rating
- Overweight
- Price target
- $8
- Median target, all firms
- $8
- Actions on LFST
- 3
Morgan Stanley price target on LFST
Every Morgan Stanley rating on LFST
- Jan 6, 2023
- Dec 17, 2021
- Aug 16, 2021
How other firms rate LFST
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Goldman Sachs | Neutral | $9 | Jun 5, 2026 |
| Barclays | Overweight | $8 | Dec 9, 2025 |
| BMO Capital Markets | Outperform | $8 | Nov 13, 2025 |
Questions about Morgan Stanley and LFST
- What is Morgan Stanley's price target for LFST?
- Morgan Stanley's latest stated price target for LifeStance Health Group Inc. (LFST) is $8, from its action on Jan 6, 2023.
- What is Morgan Stanley's rating on LFST?
- Morgan Stanley rates LFST Overweight, a bullish rating, as of Jan 6, 2023.
- When did Morgan Stanley last change its view on LFST?
- On Jan 6, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $8.
- How does Morgan Stanley's LFST target compare with other analysts?
- Across 3 firms with a LFST price target in the last 12 months, the median target is $8.
All Morgan Stanley ratingsLFST news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.